O'Flaherty E - Search Results

1

Bone marrow stromal function from patients after bone marrow transplantation.

O'Flaherty E, Sparrow R, Szer J. O'Flaherty E, et al. Bone Marrow Transplant. 1995 Feb;15(2):207-12. Bone Marrow Transplant. 1995. PMID: 7539666

2

Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic progenitor cells.

Sparrow RL, O'Flaherty E, Blanksby TM, Szer J, Van Der Weyden MB. Sparrow RL, et al. Leuk Res. 1997 Jan;21(1):29-36. doi: 10.1016/s0145-2126(96)00068-9. Leuk Res. 1997. PMID: 9029183

3

Human marrow T cell dose correlates with severity of subsequent acute graft-versus-host disease.

Atkinson K, Farrelly H, Cooley M, O'Flaherty E, Downs K, Biggs J. Atkinson K, et al. Bone Marrow Transplant. 1987 Jun;2(1):51-7. Bone Marrow Transplant. 1987. PMID: 3332157

4

CD4+ T cells appear capable of initiating graft-versus-host disease across non-major histocompatibility complex (MHC) barriers in man.

Atkinson K, Cooley M, Farrelly H, O'Flaherty E, Ashby M, Biggs J. Atkinson K, et al. Bone Marrow Transplant. 1987 Jun;2(1):79-84. Bone Marrow Transplant. 1987. PMID: 2901876

5

T cell depletion of human bone marrow for allogeneic marrow transplantation.

Farrelly H, Cooley M, O'Flaherty E, Biggs J, Atkinson K. Farrelly H, et al. Transplant Proc. 1987 Apr;19(2):2855-7. Transplant Proc. 1987. PMID: 3551227 No abstract available.

6

Viability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma: potential role in further increasing dose-intensity.

O'Flaherty E, Cebon J, Grigg AP. O'Flaherty E, et al. Leuk Lymphoma. 1997 Oct;27(3-4):343-9. doi: 10.3109/10428199709059689. Leuk Lymphoma. 1997. PMID: 9402332

7

T cell depletion of bone marrow for clinical marrow allografting: optimalization of conditions for depletion by anti-CD2 and anti-CD8 monoclonal antibodies with rabbit complement, and for detection of residual T cell content.

Cooley MA, Farrelly H, O'Flaherty E, Biggs JC, Atkinson K. Cooley MA, et al. Pathology. 1987 Apr;19(2):131-6. doi: 10.3109/00313028709077123. Pathology. 1987. PMID: 2899866

8

Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors.

Rasko JE, O'Flaherty E, Begley CG. Rasko JE, et al. Stem Cells. 1997;15(1):33-42. doi: 10.1002/stem.150033. Stem Cells. 1997. PMID: 9007220

9

Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.

Purtill D, Hutchins C, Kennedy G, McClean A, Fraser C, Shaw PJ, Chiappini P, Tao H, Ma DD, Kabani K, Bai L, Greenwood M, Bajel A, O'Flaherty E, Curtis DJ, Purins L, Perera T, Tan S, Butler A, Micklethwaite K, Antonenas V, Gottlieb D, Hamad N. Purtill D, et al. Transplant Cell Ther. 2021 Dec;27(12):1022.e1-1022.e6. doi: 10.1016/j.jtct.2021.09.012. Epub 2021 Sep 24. Transplant Cell Ther. 2021. PMID: 34571211 Free PMC article.

10

Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.

Purtill D, Antonenas V, Chiappini P, Tong D, O'Flaherty E, Bajel A, Kabani K, Larsen S, Tan S, Hutchins C, Curtis DJ, Kennedy GA, Watson AM, Bai L, Greenwood M, Gottlieb DJ, Hamad N. Purtill D, et al. Blood Adv. 2020 Sep 8;4(17):4147-4150. doi: 10.1182/bloodadvances.2020002431. Blood Adv. 2020. PMID: 32886750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters